Hepion Pharmaceuticals In...

0.29
0.01 (2.11%)
At close: Apr 24, 2025, 3:59 PM
0.29
-0.03%
After-hours: Apr 24, 2025, 07:04 PM EDT
2.11%
Bid 0.27
Market Cap 3.18M
Revenue (ttm) n/a
Net Income (ttm) -13.19M
EPS (ttm) -5367.5
PE Ratio (ttm) n/a
Forward PE n/a
Analyst n/a
Ask 0.3
Volume 712,411
Avg. Volume (20D) 4,043,162
Open 0.28
Previous Close 0.28
Day's Range 0.27 - 0.30
52-Week Range 0.25 - 79.50
Beta 1.80

About HEPA

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH...

Industry Biotechnology
Sector Healthcare
IPO Date Feb 10, 2014
Employees 22
Stock Exchange NASDAQ
Ticker Symbol HEPA
Full Company Profile
1 month ago
-39.15%
Hepion Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription
3 months ago
-58.05%
Hepion Pharmaceuticals shares are trading lower after the company announced a $9 million public offering.